Previous close | 12.00 |
Open | N/A |
Bid | 18.10 |
Ask | 20.50 |
Strike | 35.00 |
Expiry date | 2025-01-17 |
Day's range | 12.00 - 12.00 |
Contract range | N/A |
Volume | |
Open interest | 1 |
Catalent's (CTLT) new tie-up to support the development and commercial manufacturing of safe, high-quality AAV gene therapies to provide life-saving treatments to cancer patients.
Catalent (CTLT) reports a solid revenue uptick in third-quarter fiscal 2024 despite lower revenues in Biologics segments.
Insightful Analysis of Catalent Inc's Strengths, Weaknesses, Opportunities, and Threats